Aledade Primary Care ACO LLC
4550 Montgomery Ave, Ste 950
Bethesda, MD 20814
ACO Participants | ACO Participant in Joint Venture |
Penn Medicine-PMA | N |
Member First Name | Member Last Name | Member Title/Position | Member's Voting Power (Expressed as a percentage) | Membership Type | ACO Participant Legal Business Name |
MARK | BROWN | Board Member | 8.33333333 | ACO Participant Representative |
Penn Medicine-PMA |
JONATHAN | BUSSENGER | Board Member | 8.33333333 | ACO Participant Representative |
Penn Medicine-PMA |
CHRIS | DIDOMENICO | Board Member/Medicare Beneficiary Representative | 8.33333333 | Medicare Beneficiary Representative |
Penn Medicine-PMA |
JOEL | EISNER | Board Member | 8.33333333 | ACO Participant Representative |
Penn Medicine-PMA |
LEROY | FLEISCHER | Board Member/ACO Medical Director | 8.33333333 | ACO Participant Representative |
Penn Medicine-PMA |
JEFF | MANDEL | Board Member/Chair | 8.33333333 | Other | Aledade |
MANJULA | RAMAN | Board Member | 8.33333333 | ACO Participant Representative |
Penn Medicine-PMA |
KARL | SCHWABE | Board Member/Compliance Committee Lead | 8.33333333 | ACO Participant Representative |
Penn Medicine-PMA |
ROY | SCHWARTZ | Board Member | 8.33333333 | ACO Participant Representative |
Penn Medicine-PMA |
CHARLES | SCHWARTZ | Board Member | 8.33333333 | ACO Participant Representative |
Penn Medicine-PMA |
JILLIAN | WAWRZYNIAK | Board Member | 8.33333333 | ACO Participant Representative |
Penn Medicine-PMA |
YORK | YANG | Board Member | 8.33333333 | ACO Participant Representative |
Penn Medicine-PMA |
- Executive Director: Dr. Jeff Mandel
- Medical Director: Leroy Fleischer
- Compliance Officer: Ms. Amy Youtz
- Quality Assurance/Improvement Officer: Emily Maxson
Committee Name | Committee Leader Name |
Compliance Committee | Karl Schwabe / Compliance Committee Leader |
Networks of individual practices of ACO professionals.
-
Third Agreement Period
-
Performance Year 2021, $ 9,245,805
-
Performance Year 2020, $ 7,731,029
-
-
Second Agreement Period
-
Performance Year 2019, $0
-
-
First Agreement Period
- Performance Year 2018, $0
- Performance Year 2017, $0
- Performance Year 2016, $0
- Performance Year 2015, $0
Third Agreement Period
- Performance Year 2021
- Proportion invested in infrastructure: 20%
- Proportion invested in redesigned care processes/resources: 30%
- Proportion of distribution to ACO participants: 50%
- Performance Year 2020
- Proportion invested in infrastructure: 10%
- Proportion invested in redesigned care processes/resources: 35%
- Proportion of distribution to ACO participants: 55%
Please note, the Quality ID #: 370 Depression Remission at 12 months quality measure is not included in public reporting due to low sample size.
For Previous Years’ Financial and Quality Performance Results, Please Visit data.cms.gov.
Skilled Nursing Facility (SNF) 3-Day Rule Waiver: N/A
Waiver for Payment for Telehealth Services: N/A
ACO Pre-Participation Waiver:: N/A
ACO Participation Waiver: N/A